US 11654166
Therapeutic bacteriophage compositions for treating Staphylococcus infection
granted A61KA61K2300/00A61K31/395
Quick answer
US patent 11654166 (Therapeutic bacteriophage compositions for treating Staphylococcus infection) held by Armata Pharmaceuticals, Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Armata Pharmaceuticals, Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2300/00, A61K31/395, A61K31/43, A61K31/47